NP-10679

DB18040InvestigationalSmall molecule

NP-10679: Overview.

Mechanism: Pharmacologically active on Glutamate receptor ionotropic, NMDA 2B
Curator reviewed
Also known as: (R)-6-(2-hydroxy-3-(4-(4-(trifluoromethyl)phenyl)piperazin- 1-yl)propoxy)-3,4-dihydroquinolin-2(1H)-one
Code names: NP-10679

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with NP-10679, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.